Predicting the Impact of ARHGAP33 Gene on Liver Cancer Prognosis Based on Multi-Algorithm Model
The expression level of ARHGAP33 affects HCC prognosis, and its synergistic overexpression with SFPQ impairs the prognosis of HCC patients. ARHGAP33 could potentially be used as a biomarker for evaluating prognosis in hepatocellular carcinoma (HCC), offering a new theoretical foundation for enhancing HCC outcomes.
Authors
- Shen Xiaotong
- Chenjie Wang (ORCID: https://orcid.org/0000-0001-9207-2076)
- Xueling Chen
- Huijiao Jiang
- Xinhui Cao
- Yaohui Zhao
- Zi Wang
Institutions
- Shihezi University (CN)
- Xinjiang Production and Construction Corps (CN)
- First Affiliated Hospital of Shihezi University Medical College (CN)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2026-01-01
- DOI
- https://doi.org/10.2147/ijgm.s571357
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00